Jian Sun

S. Qiu, Jia Fan, Jian Zhou, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.

Zhi-quan Wu, Zhao-You Tang, Z. Wang, 2005, Chinese medical journal.

Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.

S. Qiu, Ya Cao, Jia Fan, 2017, The oncologist.

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection

S. Qiu, Ya Cao, Jia Fan, 2016, British Journal of Cancer.

Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection

S. Qiu, Q. Gao, Yong-sheng Xiao, 2009, Journal of Cancer Research and Clinical Oncology.

The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth

S. Qiu, Jian Sun, Yong Yi, 2022, Cellular oncology.

Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation

Z. Wang, S. Qiu, Jia Fan, 2013, Transplantation.

Thrombin is a therapeutic target for metastatic osteopontin‐positive hepatocellular carcinoma

Q. Ye, L. Qin, Q. Dong, 2010, Hepatology.

WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma

L. You, Taiping Zhang, Yupei Zhao, 2017, Oncology letters.

Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

Jian Sun, S. Qiu, Jia Fan, 2022, Frontiers in Oncology.

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation

Z. Wang, Zhao-You Tang, S. Qiu, 2011, PloS one.

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

S. Qiu, Jian Zhou, Jian Sun, 2023, Signal Transduction and Targeted Therapy.

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection

S. Qiu, Jia Fan, Jian Zhou, 2016, Medicine.

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

Xianghuo He, S. Qiu, Q. Gao, 2012, Cancer research.

A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection

S. Qiu, Jia Fan, Jian Zhou, 2018, Journal of surgical oncology.

Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection

Q. Ye, L. Qin, Zhao-You Tang, 2010, Gut.

Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial.

S. Qiu, Q. Gao, Jia Fan, 2021 .

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway

Tong Zhang, Zhenjiang Ma, Lijuan Liu, 2018, Cell Death & Disease.

The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma

Q. Ye, L. Qin, Q. Dong, 2009, Journal of Cancer Research and Clinical Oncology.

Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation

Z. Wang, S. Qiu, Jia Fan, 2010, Journal of Cancer Research and Clinical Oncology.

[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].

Q. Ye, L. Qin, Q. Dong, 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

Xianghuo He, S. Qiu, Q. Gao, 2012, Cancer research.

Infiltrating Memory/Senescent T Cell Ratio Predicts Extrahepatic Metastasis of Hepatocellular Carcinoma

S. Qiu, Q. Gao, Yong-sheng Xiao, 2012, Annals of Surgical Oncology.